Endocannabinoid System: Chemical Characteristics and Biological Activity

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• The endocannabinoid system (eCB) comprises cannabinoid receptors, endogenous ligands, and enzymes crucial for energy balance and cognition.
• Cannabinoids exert physiological effects via interactions with receptors like CB1, CB2, vanilloid receptors, and GPRs (GPR55, GPR3, GPR6, GPR12, GPR19).
• Anandamide (AEA) and 2-arachidoylglycerol (2-AG) are key endogenous ligands with high affinity for CB1 and CB2 receptors.

Purpose of the Study:

• To describe the components of the endocannabinoid system.
• To discuss how phytocannabinoids and exogenous compounds modulate eCB balance.
• To explore the relationship between eCB (hypo- or hyperfunctionality) and chronic pain/mood disorders.

Main Methods:

• Literature review of the endocannabinoid system's molecular structures and functions.
• Analysis of cannabinoid interactions with various receptors.
• Discussion of eCB's role in physiological and pathological conditions.

Main Results:

• The eCB system is integral to maintaining homeostasis and cognitive functions.
• Cannabinoids, including phytocannabinoids and synthetic forms, exhibit varied affinities for eCB targets.
• eCB dysfunction is implicated in chronic pain and mood disorders.

Conclusions:

• The endocannabinoid system presents significant therapeutic potential for neurological diseases.
• Phytocannabinoids and other exogenous compounds can regulate eCB balance.
• Integrative and complementary health practices may help harmonize eCB function in managing chronic pain and mood disorders.